DK0755265T3 - Kombination af væksthormon og insulinlignedne vækstfaktor til behandling af congestivt hjertesvigt - Google Patents

Kombination af væksthormon og insulinlignedne vækstfaktor til behandling af congestivt hjertesvigt

Info

Publication number
DK0755265T3
DK0755265T3 DK95914882T DK95914882T DK0755265T3 DK 0755265 T3 DK0755265 T3 DK 0755265T3 DK 95914882 T DK95914882 T DK 95914882T DK 95914882 T DK95914882 T DK 95914882T DK 0755265 T3 DK0755265 T3 DK 0755265T3
Authority
DK
Denmark
Prior art keywords
combination
heart failure
mammal
congestive heart
insulin
Prior art date
Application number
DK95914882T
Other languages
English (en)
Inventor
Renhui Yang
Ross G Clark
Hongkui Jin
Nicholas F Paoni
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,859 external-priority patent/US5661122A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0755265T3 publication Critical patent/DK0755265T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
DK95914882T 1994-04-15 1995-03-30 Kombination af væksthormon og insulinlignedne vækstfaktor til behandling af congestivt hjertesvigt DK0755265T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22792394A 1994-04-15 1994-04-15
US08/284,859 US5661122A (en) 1994-04-15 1994-08-02 Treatment of congestive heart failure
US08/333,909 US5610134A (en) 1994-04-15 1994-11-03 Treatment of congestive heart failure
PCT/US1995/003755 WO1995028174A1 (en) 1994-04-15 1995-03-30 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure

Publications (1)

Publication Number Publication Date
DK0755265T3 true DK0755265T3 (da) 2002-03-04

Family

ID=27397790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914882T DK0755265T3 (da) 1994-04-15 1995-03-30 Kombination af væksthormon og insulinlignedne vækstfaktor til behandling af congestivt hjertesvigt

Country Status (13)

Country Link
US (1) US5610134A (da)
EP (1) EP0755265B1 (da)
JP (1) JP3473623B2 (da)
AT (1) ATE208209T1 (da)
AU (1) AU691273B2 (da)
CA (1) CA2185998C (da)
DE (1) DE69523747T2 (da)
DK (1) DK0755265T3 (da)
ES (1) ES2167427T3 (da)
HK (1) HK1003418A1 (da)
LV (1) LV12966B (da)
PT (1) PT755265E (da)
WO (1) WO1995028174A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3182307B2 (ja) * 1994-12-27 2001-07-03 株式会社荏原製作所 全周流型ポンプ
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) * 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
US6306826B1 (en) 1997-06-04 2001-10-23 The Regents Of The University Of California Treatment of heart failure with growth hormone
US6015384A (en) * 1998-08-31 2000-01-18 Acuson Corporation Ultrasonic system and method for tissue viability imaging
SE9901634D0 (sv) * 1999-05-05 1999-05-05 Sahltech Ab Treatment of myocardial infarction with a substance related to the growth hormone axis
WO2001003720A2 (en) * 1999-07-12 2001-01-18 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
BR0013162A (pt) * 1999-07-12 2002-05-28 Grandis Biotech Gmbh Formulações de hormÈnio de crescimento
US6800604B2 (en) * 2000-02-11 2004-10-05 Genentech, Inc. Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
FR2805051B1 (fr) * 2000-02-14 2002-12-06 Geophysique Cie Gle Methode de surveillance sismique d'une zone souterraine par utilisation simultanee de plusieurs sources vibrosismiques
EP2075253A1 (en) 2000-06-23 2009-07-01 Genentech, Inc. Compositions and methds for the diagnosis and treatment of disorders involving angiogensis
EP2275549A1 (en) 2000-06-23 2011-01-19 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US20020098167A1 (en) 2000-07-31 2002-07-25 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20030224984A1 (en) * 2001-06-20 2003-12-04 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US6607517B1 (en) 2001-08-24 2003-08-19 Radiant Medical, Inc. Method of inotropic treatment of heart disease using hypothermia
BR0317888A (pt) 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
EP1841443A4 (en) * 2005-01-11 2012-05-02 Heart Failure Technologies Inc METHOD AND SYSTEM FOR TREATING HEART ERRORS
AU2008323719B2 (en) 2007-11-09 2013-04-04 New York Medical College Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor
EP2227238A2 (en) 2007-11-30 2010-09-15 New York Medical College Compositions comprising vascular and myocyte progenitor cells and methods of their use
US8512696B2 (en) 2007-11-30 2013-08-20 Autologous, Llc Methods of isolating non-senescent cardiac stem cells and uses thereof
AU2008334036B2 (en) 2007-11-30 2014-05-29 New York Medical College Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
ATE133073T1 (de) * 1990-10-25 1996-02-15 Genentech Inc Verwendung gegen reaktive sauerstoffverbindungen schützender wirkstoffe
SE9100099D0 (sv) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
SE9101840L (sv) * 1991-06-14 1992-12-15 Kabi Pharmacia Ny medicinsk anvaendning
WO1993000109A1 (en) * 1991-06-28 1993-01-07 Genentech, Inc. Method of stimulating immune response using growth hormone
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response

Also Published As

Publication number Publication date
US5610134A (en) 1997-03-11
AU691273B2 (en) 1998-05-14
DE69523747D1 (de) 2001-12-13
HK1003418A1 (en) 1998-10-30
LV12966B (en) 2003-05-20
ES2167427T3 (es) 2002-05-16
CA2185998A1 (en) 1995-10-26
PT755265E (pt) 2002-04-29
AU2195695A (en) 1995-11-10
WO1995028174A1 (en) 1995-10-26
CA2185998C (en) 2011-02-22
DE69523747T2 (de) 2002-08-01
JPH09512008A (ja) 1997-12-02
EP0755265A1 (en) 1997-01-29
JP3473623B2 (ja) 2003-12-08
ATE208209T1 (de) 2001-11-15
EP0755265B1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
DK0755265T3 (da) Kombination af væksthormon og insulinlignedne vækstfaktor til behandling af congestivt hjertesvigt
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
ID17768A (id) Metoda pengobatan
ATE374526T1 (de) Lösung und verfahren zur wiederbelebung und heilung von ischämisch beschädigtem gewebe
BG97068A (bg) Фармацевтичен състав и метод за постигане на терапевтичен ефект
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
DE69617469T2 (de) Behandlung von multipler sklerose
WO2003020202A3 (en) Method for reducing hypertension and heart failure
ATE211921T1 (de) Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
DE69904010D1 (de) Verwendung von vip zur erstellung eines medikamentes zur behandlung des endotoxischen schocks in säugetieren
MX9604803A (es) Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo.
EA200000140A1 (ru) Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
ATE149840T1 (de) Behandlung von leberkrebs
EA200000040A1 (ru) Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы
ATE239497T1 (de) Verwendung von urodilatin zur behandlung chronischer niereninsuffizienz mit nierenrestfunktionen
DK381085D0 (da) Fremgangsmaade og middel til bekaempelse af luseangreb
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE329600T1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
DE69519681T2 (de) Behandlung von tieren
MY118982A (en) Method of reducing tissue damage associated with ischemia
DE69826287D1 (de) Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung
RU97112226A (ru) Способ лечения хронического бронхита у больных с сопутствующим остеоартрозом
NO950299D0 (no) Anti-inflammatoriske peptidanaloger og behandling for å inhibere vaskulær lekkasje i skadet vev